首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   14260篇
  免费   987篇
  国内免费   184篇
耳鼻咽喉   225篇
儿科学   261篇
妇产科学   180篇
基础医学   2401篇
口腔科学   210篇
临床医学   1210篇
内科学   2909篇
皮肤病学   718篇
神经病学   1030篇
特种医学   1111篇
外科学   1602篇
综合类   32篇
现状与发展   1篇
一般理论   2篇
预防医学   487篇
眼科学   443篇
药学   1429篇
中国医学   258篇
肿瘤学   922篇
  2024年   9篇
  2023年   117篇
  2022年   425篇
  2021年   614篇
  2020年   310篇
  2019年   425篇
  2018年   509篇
  2017年   409篇
  2016年   635篇
  2015年   750篇
  2014年   935篇
  2013年   953篇
  2012年   1375篇
  2011年   1334篇
  2010年   773篇
  2009年   651篇
  2008年   863篇
  2007年   741篇
  2006年   611篇
  2005年   604篇
  2004年   438篇
  2003年   389篇
  2002年   341篇
  2001年   204篇
  2000年   209篇
  1999年   151篇
  1998年   61篇
  1997年   40篇
  1996年   43篇
  1995年   30篇
  1994年   42篇
  1993年   25篇
  1992年   44篇
  1991年   47篇
  1990年   41篇
  1989年   53篇
  1988年   31篇
  1987年   36篇
  1986年   26篇
  1985年   25篇
  1984年   12篇
  1983年   7篇
  1981年   9篇
  1980年   16篇
  1979年   15篇
  1978年   7篇
  1977年   9篇
  1971年   4篇
  1970年   4篇
  1967年   4篇
排序方式: 共有10000条查询结果,搜索用时 140 毫秒
1.
Erythema induratum of Bazin (EIB) is a form of tuberculid resulting from hypersensitivity to tuberculosis antigen. EIB occurs most commonly in middle‐aged women and is not typically seen in children. Here, we present a rare case of EIB, presenting as a chronic nodular panniculitis, in a 10‐year‐old Korean boy.  相似文献   
2.
3.
4.
5.
6.
7.
8.
9.

Background and aims

It is not known whether non alcoholic fatty liver disease (NAFLD) is a risk factor for diabetes in non obese, non centrally-obese subjects. Our aim was to investigate relationships between fatty liver, insulin resistance and a biomarker score for liver fibrosis with incident diabetes at follow up, in subjects who were neither obese nor centrally-obese.

Methods and results

As many as 70,303 subjects with a body mass index (BMI) < 25 kg/m2 and without diabetes were followed up for a maximum of 7.9 years. At baseline, fatty liver was identified by liver ultrasound, insulin resistance (IR) by homeostatic model assessment of insulin resistance (HOMA-IR) ≥2.0, and central obesity by waist circumference (waist circumference ≥90 cm (men) and ≥85 cm (women). The Fibrosis-4 (FIB-4 score) was used to estimate extent of liver fibrosis. Cox proportional hazards models adjusted for confounders were used to estimate hazard ratios (aHRs) for incident diabetes. As many as 852 incident cases of diabetes occurred during follow up (median [IQR] 3.71 [2.03] years). Mean ± SD BMI was 22.8 ± 1.8 and 21.7 ± 2.0 kg/m2 in subjects with and without diabetes at follow up. In subjects without central obesity and with fatty liver, aHRs (95% CI) for incident diabetes at follow up were 2.17 (1.56, 3.03) for men, and 2.86 (1.50,5.46) for women. Similar aHRs for incident diabetes occurred with fatty liver, IR and the highest quartile of FIB-4 combined, in men; and there was a non significant trend toward increased risk in women.

Conclusions

In normal weight, non-centrally obese subjects NAFLD is an independent risk factor for incident diabetes.  相似文献   
10.
ABSTRACT

Genotoxic compounds may be detoxified to non-genotoxic metabolites while many pro-carcinogens require metabolic activation to exert their genotoxicity in vivo. Standard genotoxicity assays were developed and utilized for risk assessment for over 40 years. Most of these assays are conducted in metabolically incompetent rodent or human cell lines. Deficient in normal metabolism and relying on exogenous metabolic activation systems, the current in vitro genotoxicity assays often have yielded high false positive rates, which trigger unnecessary and costly in vivo studies. Metabolically active cells such as hepatocytes have been recognized as a promising cell model in predicting genotoxicity of carcinogens in vivo. In recent years, significant advances in tissue culture and biological technologies provided new opportunities for using hepatocytes in genetic toxicology. This review encompasses published studies (both in vitro and in vivo) using hepatocytes for genotoxicity assessment. Findings from both standard and newly developed genotoxicity assays are summarized. Various liver cell models used for genotoxicity assessment are described, including the potential application of advanced liver cell models such as 3D spheroids, organoids, and engineered hepatocytes. An integrated strategy, that includes the use of human-based cells with enhanced biological relevance and throughput, and applying the quantitative analysis of data, may provide an approach for future genotoxicity risk assessment.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号